Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 5.32%1.08T | 14.39%1.17T | 1.79%988.52B | 3.71%4.18T | 0.57%1.16T | 2.93%1.03T | 2.21%1.02T | 10.44%971.13B | 14.75%4.03T | 21.11%1.16T |
Cost of revenue | 3.73%563.45B | 14.94%616.2B | -1.36%510.08B | 0.38%2.21T | -3.63%615.64B | -0.34%543.2B | 0.25%536.11B | 6.63%517.12B | 16.87%2.2T | 23.42%638.84B |
Gross profit | 7.12%516.36B | 13.78%551.59B | 5.38%478.44B | 7.72%1.97T | 5.74%548.08B | 6.88%482.05B | 4.47%484.77B | 15.12%454.01B | 12.29%1.83T | 18.38%518.34B |
Operating expense | 4.70%418.2B | 10.37%433.2B | 7.80%398.36B | 8.08%1.59T | 2.63%432.09B | 8.07%399.43B | 7.37%392.5B | 16.11%369.54B | 9.55%1.47T | 16.14%421B |
Selling and administrative expenses | 6.92%336.91B | 13.59%348.14B | 8.83%318.91B | 8.05%1.26T | 3.48%347B | 6.97%315.1B | 5.38%306.49B | 18.68%293.04B | 10.31%1.17T | 17.18%335.34B |
-General and administrative expense | --336.91B | --348.14B | 8.83%318.91B | 8.05%1.26T | ---- | ---- | ---- | --293.04B | --1.17T | ---- |
Research and development costs | -3.60%81.29B | -1.10%85.06B | 3.86%79.45B | 8.21%331.91B | -0.67%85.08B | 12.41%84.33B | 15.10%86.01B | 7.23%76.5B | 6.75%306.73B | 12.22%85.66B |
Operating profit | 18.81%98.16B | 28.30%118.39B | -5.20%80.08B | 6.22%375.37B | 19.16%115.99B | 1.45%82.62B | -6.30%92.27B | 10.95%84.48B | 25.36%353.4B | 29.18%97.34B |
Net non-operating interest income (expenses) | -2.59%2.82B | 10.29%2.95B | 60.10%3.31B | 170.10%11.16B | 107.47%3.53B | 116.55%2.89B | 270.74%2.67B | 452.14%2.07B | 160.63%4.13B | 234.84%1.7B |
Non-operating interest income | 7.83%3.83B | 20.14%3.79B | 64.30%3.94B | 159.32%13.43B | 115.02%4.32B | 130.22%3.55B | 210.52%3.16B | 293.91%2.4B | 131.94%5.18B | 181.91%2.01B |
Non-operating interest expense | 53.57%1.01B | 74.43%846M | 90.61%629M | 116.73%2.27B | 156.63%793M | 218.36%659M | 63.85%485M | 41.03%330M | 61.67%1.05B | 50.73%309M |
Net investment income | ||||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | ||||||||||
Other non-operating income (expenses) | -745.87%-11.66B | 76.12%10.89B | 486.82%5.83B | 183.36%4.24B | -122.11%-4.74B | 148.80%1.81B | 144.15%6.18B | 111.27%994M | -126.51%-5.09B | 597.58%21.43B |
Income before tax | 2.29%89.32B | 30.75%132.23B | 1.93%89.22B | 10.87%390.77B | -4.72%114.79B | 10.43%87.32B | 18.70%101.13B | 29.30%87.53B | 16.43%352.44B | 68.35%120.47B |
Income tax | -25.67%15.89B | 19.45%36.75B | -3.05%25.02B | 15.15%106.35B | -6.58%28.4B | -2.05%21.38B | 38.40%30.77B | 44.12%25.8B | 28.51%92.36B | 273.76%30.39B |
Net income | 11.36%73.43B | 35.69%95.47B | 4.01%64.21B | 9.36%284.42B | -4.09%86.39B | 15.18%65.94B | 11.74%70.36B | 23.97%61.73B | 12.67%260.08B | 42.02%90.08B |
Net income continuous operations | 11.36%73.43B | 35.69%95.47B | 4.01%64.21B | 9.36%284.42B | -4.09%86.39B | 15.18%65.94B | 11.74%70.36B | 23.97%61.73B | 12.67%260.08B | 42.02%90.08B |
Noncontrolling interests | 22.64%4.67B | 13.27%5.62B | -20.00%4.26B | 23.48%19.91B | 11.27%5.82B | 21.59%3.81B | 25.81%4.96B | 39.34%5.32B | 0.01%16.12B | 44.23%5.23B |
Net income attributable to the company | 10.67%68.76B | 37.39%89.86B | 6.27%59.95B | 8.42%264.51B | -5.04%80.57B | 14.81%62.13B | 10.81%65.4B | 22.70%56.41B | 13.62%243.96B | 41.88%84.84B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Net income attributable to common stockholders | 10.67%68.76B | 37.39%89.86B | 6.27%59.95B | 8.42%264.51B | -5.04%80.57B | 14.81%62.13B | 10.81%65.4B | 22.70%56.41B | 13.62%243.96B | 41.88%84.84B |
Gross dividend payment | ||||||||||
Basic earnings per share | 14.73%71.88 | 41.76%91.83 | 9.25%60.7 | 11.61%264.2 | -2.38%81.5612 | 18.43%62.65 | 13.95%64.78 | 26.36%55.56 | 15.27%236.71 | 46.11%83.5469 |
Diluted earnings per share | 14.74%71.85 | 41.75%91.78 | 9.26%60.67 | 11.60%264.08 | -2.38%81.5612 | 18.42%62.62 | 13.94%64.75 | 26.32%55.53 | 15.27%236.63 | 46.11%83.5469 |
Dividend per share | 0 | 7.14%75 | 0 | 16.67%140 | 16.67%70 | 0 | 16.67%70 | 0 | 20.00%120 | 9.09%60 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |